Stacy Fuhrmann

486 total citations
8 papers, 391 citations indexed

About

Stacy Fuhrmann is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Stacy Fuhrmann has authored 8 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Stacy Fuhrmann's work include Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (3 papers) and Adenosine and Purinergic Signaling (2 papers). Stacy Fuhrmann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (3 papers) and Adenosine and Purinergic Signaling (2 papers). Stacy Fuhrmann collaborates with scholars based in United States, Switzerland and Russia. Stacy Fuhrmann's co-authors include Kathy Mulgrew, Scott A. Hammond, Kris F. Sachsenmeier, Raymond Rothstein, Edmund Poon, Carl Hay, Qihui Huang, Kelly McGlinchey, Erin Sult and Robert E. Hollingsworth and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Stacy Fuhrmann

8 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stacy Fuhrmann United States	5	206	158	134	127	80	8	391
Emily Piccione United States	9	307 1.5×	278 1.8×	124 0.9×	101 0.8×	107 1.3×	18	537
Guillaume Chouinard Belgium	3	198 1.0×	143 0.9×	198 1.5×	100 0.8×	8 0.1×	3	373
I Montalban del Barrio Germany	5	175 0.8×	224 1.4×	204 1.5×	104 0.8×	7 0.1×	5	412
Nicole Milenkovski Canada	4	239 1.2×	197 1.2×	154 1.1×	79 0.6×	5 0.1×	4	368
Cegui Hu China	12	75 0.4×	52 0.3×	49 0.4×	144 1.1×	22 0.3×	21	339
Yoko Nishiga United States	3	138 0.7×	182 1.2×	11 0.1×	109 0.9×	29 0.4×	3	302
Farnaz Hajizadeh Iran	9	132 0.6×	125 0.8×	43 0.3×	143 1.1×	8 0.1×	10	349
Daniela Cerezo‐Wallis Spain	9	49 0.2×	103 0.7×	36 0.3×	142 1.1×	16 0.2×	11	271
Angela Oppelt Norway	6	50 0.2×	35 0.2×	33 0.2×	191 1.5×	16 0.2×	6	358
Kyle B. Lupo United States	9	380 1.8×	448 2.8×	65 0.5×	99 0.8×	5 0.1×	12	584

Countries citing papers authored by Stacy Fuhrmann

Since Specialization

Citations

This map shows the geographic impact of Stacy Fuhrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy Fuhrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy Fuhrmann more than expected).

Fields of papers citing papers by Stacy Fuhrmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacy Fuhrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy Fuhrmann. The network helps show where Stacy Fuhrmann may publish in the future.

Co-authorship network of co-authors of Stacy Fuhrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Stacy Fuhrmann. A scholar is included among the top collaborators of Stacy Fuhrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacy Fuhrmann. Stacy Fuhrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Hay, Carl, Erin Sult, Qihui Huang, et al.. (2016). Targeting CD73 in the tumor microenvironment with MEDI9447. OncoImmunology. 5(8). e1208875–e1208875. 229 indexed citations

Hay, Carl, Erin Sult, Qihui Huang, et al.. (2015). Abstract 285: MEDI9447: enhancing anti-tumor immunity by targeting CD73 In the tumor microenvironment. Cancer Research. 75(15_Supplement). 285–285. 10 indexed citations

Oberst, Michael D., Stacy Fuhrmann, Kathy Mulgrew, et al.. (2014). CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas. mAbs. 6(6). 1571–1584. 71 indexed citations

Fuhrmann, Stacy, Maria Amann, Kathy Mulgrew, et al.. (2010). Abstract 5625: In vitro and in vivo pharmacology of MEDI-565 (MT111), a novel CEA/CD3-bispecific single-chain BiTE antibody in development for the treatment of gastrointestinal adenocarcinomas. Cancer Research. 70(8_Supplement). 5625–5625. 1 indexed citations

Bruckheimer, Elizabeth, Christine Fazenbaker, Sandra Gallagher, et al.. (2009). Antibody-Dependent Cell-Mediated Cytotoxicity Effector-Enhanced EphA2 Agonist Monoclonal Antibody Demonstrates Potent Activity against Human Tumors. Neoplasia. 11(6). 509–IN2. 29 indexed citations

Mulgrew, Kathy, David J. Stewart, Wendy L. Trigona, et al.. (2008). Bioavailability, pharmacodynamic activity, and anti-tumor efficacy of the CD19/CD3-specific BiTE antibody MEDI-538 (MT103) delivered subcutaneously in animal models. Cancer Research. 68. 2131–2131. 2 indexed citations

Park, Jung Min, Matthew J. Kohn, Monique W. Bruinsma, et al.. (2006). The Multifunctional RNA-Binding Protein La Is Required for Mouse Development and for the Establishment of EmbryonicStem Cells. Molecular and Cellular Biology. 26(4). 1445–1451. 48 indexed citations

Hammond, Scott A., Stacy Fuhrmann, Shannon Roff, et al.. (2006). Mechanistic Evaluation of Siplizumab (MEDI-507) Activity on Normal and Malignant T-Lymphocytes.. Blood. 108(11). 2504–2504. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact